Pharmacology and clinical potential of oblimersen sodium in the treatment of chronic lymphocytic leukemia
Gautam Borthakur, Susan O'BrienDepartment of Leukemia, MD Anderson Cancer Center, Houston, TX, USAAbstract: Targeted inhibition of the Bcl-2 family of antiapoptotic proteins is expected to improve outcomes in chronic lymphocytic leukemia. Antisense oligonucleotides and small molecule inh...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-08-01
|
| Series: | Blood and Lymphatic Cancer : Targets and Therapy |
| Online Access: | http://www.dovepress.com/pharmacology-and-clinical-potential-of-oblimersen-sodium-in-the-treatm-a10754 |